Plavix, a ‘super aspirin’ used for stroke and heart attack prevention, has been approved as a generic medication. This will be a boon to many patients as plavix is very expensive and can be cost-prohibitive.
The costs will remain high for six months usually, but then there should be a dramatic drop in cost. I’m told that Bristol-Myer-Squibb will offer the branded medication at approximately $37 per month.